Rx RadioRx Radio
HomePodcastResourcesShopNewsBusinessTechnologyClinical PracticeDrug Pricing & Access
HomePodcastResourcesShopArticlesCategoriesSearchAbout

Categories

NewsBusinessTechnologyClinical PracticeDrug Pricing & AccessEducationGlobal HealthLaw & ComplianceLeadership & DevelopmentManaged CarePatient Care & CounselingPublic HealthR&D
Rx RadioRx Radio

Leading the conversation in pharmacy

Navigation

  • Home
  • Podcast
  • Resources
  • Shop
  • Articles
  • Categories
  • Search

Categories

  • News
  • Business
  • Technology
  • Clinical Practice
  • Drug Pricing & Access
  • Education
  • Global Health

Company

  • About
  • Privacy Policy
  • Terms of Service

Follow Us

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • TikTok
  • Threads

© 2026 Rx Radio. All rights reserved.

PrivacyTerms
  1. Home
  2. Categories
  3. Clinical Practice

Clinical Practice

Gabapentin Linked to Dementia Risk: What Pharmacists Need to Know

Gabapentin Linked to Dementia Risk: What Pharmacists Need to Know

New research reveals concerning links between gabapentin use in chronic pain patients and increased dementia risk. Essential reading for pharmacists and healthcare providers.

Bridging the Diabetic Neuropathy Care Gap with the Help of a Pharmacist

Bridging the Diabetic Neuropathy Care Gap with the Help of a Pharmacist

Discover how pharmacists can close critical care gaps in diabetic neuropathy affecting 50% of diabetes patients through proactive screening, medication management, and patient education.

Expanding Pharmacists’ Role Through Test-and-Treat Services

Expanding Pharmacists’ Role Through Test-and-Treat Services

Pharmacists are increasingly positioned to enhance community health by offering point-of-care test-and-treat (POCT-and-treat) services for common infectious conditions.

Veozah (fezolinetant) Updated with Warning on Rare Serious Liver Injury

Veozah (fezolinetant) Updated with Warning on Rare Serious Liver Injury

FDA issues new liver injury warning for Veozah (fezolinetant), a menopause hot flash treatment. Learn about required monitoring, symptoms to watch, and safety updates.

FDA Approves Self-Administered Nasal Flu Vaccine, Expanding Access and Convenience

FDA Approves Self-Administered Nasal Flu Vaccine, Expanding Access and Convenience

FDA Approves First Nasal Spray for Anaphylaxis Treatment

FDA Approves First Nasal Spray for Anaphylaxis Treatment

FDA approves Neffy, the first epinephrine nasal spray for anaphylaxis treatment, offering a needle-free alternative to injections with comparable efficacy for emergency care.